Toward off-the-shelf adoptive T cell therapies.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28424328.
- Also identified by DOI 10.1126/scitranslmed.aan2779.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Artificial thymic organoids may enable more efficient engineered T cell production for immunotherapy.
Medical subject headings
- Immunotherapy
- Immunotherapy, Adoptive
- T-Lymphocytes